Splenic Hamartoma: Immunohistochemical Profile

  • Seyed Mohammad Tavangar Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Alireza Abdollahi Mail Department of Pathology, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Splenic hamartoma, Immunohistochemistry


Splenic hamartoma is an unusual accidental finding with non-neoplastic feature that may be incidentally diagnosed because of its compression effect on surrounding organs. The predominant pathological feature leading diagnosis is circumscribed, un-encapsulated bulging nodules with focal fibrosis or cyst. The histopathological feature of splenic hamartoma is the positivity for CD8, and occasionally for CD31, CD34, and CD68 biomarkers on vascular wall but the cells are frequently negative for CD21. Herein, we describe a case with initial diagnosis of nephrolithiasis due to abdominal pain that was finally confirmed as splenic hamartoma by histopathological assessments and detection of CD8, CD31, CD34, and CD68 positivity.


Lee H, Maeda K. Hamartoma of the spleen. Arch Pathol Lab Med 2009;133:147-51.

Berge TH. Splenoma. Acta Pathol Microbiol Scand 1965;63:333-9.

Hayes TC, Britton HA, Mewborne EB, Troyer DA,Saldivar VA, Ratner IA. Symptomatic splenic hamartoma: case report and literature review. Pediatrics 1998;101:10.

Soto-Medina CA, Mier-Escurra EA, Treviño-Garza F,Ripa-Galván P. Splenic hamartoma. Case report Cir Cir 2014;82:328-31.

Yazici P, Aydin U, Ersin S, Kaplan H. Hamartoma – a rare benign tumor of the spleen: a report of four cases.Eurasian J Med 2008;40:48-51.

Sim J, Ahn HI, Han H, Jun YJ, Rehman A, Jang SM, et al. Splenic hamartoma: A case report and review of the literature. World J Clin Cases 2013;1:217-9

Dong A, Wang Y, Lu J, Zuo C. Enhanced CT and FDG PET/CT findings of splenic hamartoma. Clin Nucl Med 2014;39:968-71.

Silverman ML, LiVolsi VA. Splenic hamartoma. Am J Clin Pathol 1978;70:224-9.

Wirbel RJ, Uhlig U, Futterer KM. Case report: splenic hamartoma with hematologic disorders. Am J Med Sci 1996;311:243-6.

Abbott RM, Levy AD, Aguilera NS, Gorospe L,Thompson WM. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics 2004;24:1137-63.

Arber DA, Strickler JG, Chen YY, Weiss LM. Splenic vascular tumors: a histologic, immunophenotypic, and virologic study (comment on: Am J Surg Pathol 2000;24:306–307). Am J Surg Pathol 1997;21:827-35.

Ali TZ, Beyer G, Taylor M, Volpe C, Papadimitriou JC. Splenic hamartoma: immunohistochemical and ultrastructural profile of two cases. Int J Surg Pathol 2005;13:103-11.

Giovagnoni A, Giorgi C, Goteri G. Tumours of the spleen. Cancer Imaging 2005;25:73-7.

How to Cite
Tavangar SM, Abdollahi A. Splenic Hamartoma: Immunohistochemical Profile. Acta Med Iran. 55(1):77-78.
Case Report(s)